Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 4
2012 2
2014 1
2015 2
2017 2
2018 4
2019 6
2020 5
2021 7
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Neuroblastoma.
Mahapatra S, Challagundla KB. Mahapatra S, et al. Among authors: challagundla kb. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 28846355 Free Books & Documents.
Past, Present, and a Glance into the Future of Multiple Myeloma Treatment.
Elbezanti WO, Challagundla KB, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK. Elbezanti WO, et al. Among authors: challagundla kb. Pharmaceuticals (Basel). 2023 Mar 8;16(3):415. doi: 10.3390/ph16030415. Pharmaceuticals (Basel). 2023. PMID: 36986514 Free PMC article. Review.
Immune checkpoint molecules in neuroblastoma: A clinical perspective.
Pathania AS, Prathipati P, Murakonda SP, Murakonda AB, Srivastava A, Avadhesh, Byrareddy SN, Coulter DW, Gupta SC, Challagundla KB. Pathania AS, et al. Among authors: challagundla kb. Semin Cancer Biol. 2022 Nov;86(Pt 2):247-258. doi: 10.1016/j.semcancer.2022.06.013. Epub 2022 Jul 3. Semin Cancer Biol. 2022. PMID: 35787940 Review.
miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma.
Pathania AS, Prathipati P, Olwenyi OA, Chava S, Smith OV, Gupta SC, Chaturvedi NK, Byrareddy SN, Coulter DW, Challagundla KB. Pathania AS, et al. Among authors: challagundla kb. Mol Ther Oncolytics. 2022 Mar 31;25:308-329. doi: 10.1016/j.omto.2022.03.010. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35663229 Free PMC article.
35 results